Item 5.07. Submission of Matters to a Vote of Security Holders.
On August 10, 2022, Ampio Pharmaceuticals, Inc. (the "Company" or "Ampio") held
its 2022 annual meeting of stockholders (the "Annual Meeting"). As of the close
of business on the record date of June 29, 2022, there were 226,286,867 shares
of common stock outstanding. At the Annual Meeting, the shareholders present in
person or by proxy represented 133,715,057 shares of common stock, or
approximately 59.09%.
The following describes the matters considered by the Company's stockholders at
the Annual Meeting, as well as the results of the votes cast at the Annual
Meeting.
1. To elect four directors to serve until the next annual meeting of
stockholders or until their respective successors are duly elected and
qualified.
Nominee Votes For Votes Withheld Broker Non-Votes
Michael A. Martino 68,094,372 15,260,102 50,360,583
David R. Stevens, Ph.D. 69,275,994 14,078,480 50,360,583
J. Kevin Buchi 68,440,977 14,913,497 50,360,583
Elizabeth Varki Jobes 69,492,101 13,862,373 50,360,583
As a result, each nominee was elected as a director of the Company.
2. To ratify the selection of Moss Adams LLP as the independent registered
public accounting firm for Ampio Pharmaceuticals, Inc. for the year ending
December 31, 2022.
Votes For Votes Against Abstentions
124,178,529 4,791,788 4,744,740
As a result, the selection of Moss Adams LLP as the independent registered
public accounting firm of the Company for the year ending December 31, 2022 was
ratified.
3. To approve an amendment to the Ampio Pharmaceuticals certificate of
incorporation to effect a reverse stock split of the Company's common stock at a
ratio not less than 5-to-1 and not greater than 15-to-1, with the exact ratio to
be set within that range at the discretion of our Board of Directors before
August 10, 2023 without further approval or authorization of our stockholders.
Votes For Votes Against Abstentions
101,486,305 30,641,193 1,587,559
Accordingly, the stockholders did not approve this proposal.
3
© Edgar Online, source Glimpses
AMPIO PHARMACEUTICALS, INC. 